Mast Cell Activation Syndrome vs. Histamine Intolerance: A Naturopathic Guide to Symptoms, Gut Health, and Hormone Triggers
A Toronto naturopath's plain-language breakdown of MCAS and histamine intolerance — what they are, how they differ, why gut health and hormones (including perimenopause and menopause) play a bigger role than most people realize, and what the research actually supports.
If you've spent time in wellness or chronic illness communities, you've probably come across "mast cell activation syndrome" (MCAS) and "histamine intolerance." They get used almost interchangeably online, often as an explanation for a long list of unexplained symptoms — flushing, hives, gut health complaints, headaches, fatigue. But they're distinct conditions, with very different levels of scientific certainty behind them, and lumping them together can lead people down the wrong treatment path.
In my naturopathic practice in Toronto, these are two of the most common (and most confused) reasons people come in asking for help. Here's what the current research actually says about each one, how they differ, and where gut health and hormones fit into the picture.
What Mast Cells Do
Mast cells are immune cells found throughout your skin, gut, airways, and other tissues. When triggered, they release histamine and other chemical mediators, producing the classic allergic-type symptoms: flushing, itching, swelling, congestion, diarrhea, wheezing. This is a normal, protective process — it's how your body handles allergens and irritants.
The question in both MCAS and histamine intolerance is what happens when this system misfires or becomes overactive without an obvious trigger like a bee sting or peanut.
Mast Cell Activation Syndrome (MCAS)
MCAS is a relatively new diagnosis — it wasn't formally described until 2010, with the criteria refined in 2012 and again in 2022. That short history matters: it means the diagnostic tools are still evolving, and there's active debate among specialists about how strictly to apply them.
To meet the formal diagnostic criteria, a person needs to show all three of the following:
Recurrent, severe symptoms affecting two or more body systems at once (for example, skin and gut, or airway and cardiovascular symptoms together) — not just an isolated symptom like chronic hives on its own.
Lab evidence of mast cell involvement, such as a rise in blood tryptase (a marker mast cells release) measured during a flare and compared against the person's own baseline.
A clear, meaningful improvement with medications that target mast cells, like antihistamines or mast cell stabilizers.
That second criterion — the lab confirmation — is the most debated part of the whole framework. Catching a tryptase spike requires drawing blood within a fairly narrow window after a flare and comparing it to a known baseline, which is logistically hard to pull off in real life. Researchers acknowledge this is a genuine barrier, but skipping it isn't a great workaround either: doing so also skips the ability to rule out more serious conditions like systemic mastocytosis (a disease of mast cells accumulating in the bone marrow) or hereditary alpha-tryptasemia (a genetic trait, found in a meaningful slice of the population, that raises baseline tryptase without causing MCAS).
Why "mast cells were found" isn't the same as "you have MCAS." Mast cells live in nearly every tissue in the body, including the gut lining. Finding them, or even finding somewhat elevated numbers of them, doesn't meet the diagnostic bar. Several researchers have specifically raised concerns about overdiagnosis — pointing to papers that link mast cells to conditions like IBS without ever applying the actual MCAS criteria.
The overlap with other conditions is real, but complicated. MCAS has been proposed as a connecting thread between conditions like postural orthostatic tachycardia syndrome (POTS), Ehlers-Danlos syndrome (EDS), irritable bowel syndrome, and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). There's some genuine signal here — for instance, a majority of patients at one POTS clinic reported hives, and those with hives had a higher overall symptom burden. But when researchers have applied strict diagnostic criteria to these same populations, the overlap shrinks dramatically. One study found that using strict criteria, only 2 out of 100 POTS patients actually met the bar for MCAS — but using looser, symptom-based criteria, that number jumped to 87 out of 100. Similar symptoms don't prove a shared cause, and treating a primary condition like EDS as if it were "really" MCAS can mean the underlying issue goes undertreated.
Interestingly, treatment may still be worth trying even without a lab-confirmed diagnosis. Because getting a proper tryptase sample is so hard, some researchers argue that a cautious medication trial is reasonable in people with a strong clinical picture, especially since the first-line options (antihistamines, mast cell stabilizers) are generally low-risk. In one study, a meaningful share of patients improved on mast cell–targeted treatment even without positive lab work. The caveat: this doesn't retroactively confirm the diagnosis, and it doesn't justify jumping to riskier treatments like steroids or immunosuppressants without solid confirmation.
A practical marker to watch for: timing. Histamine has a short half-life in the body. If someone is being treated for MCAS, a real response to treatment should show up within weeks, not months. If a person has been on a mast-cell protocol for months with no change, it's worth revisiting whether MCAS is the right diagnosis at all.
Histamine Intolerance (HIT) and Gut Health
Histamine intolerance is a separate concept from MCAS, and it's worth noting upfront: it isn't formally recognized by many major medical organizations, and it lacks the kind of validated lab test or diagnostic criteria that MCAS at least attempts to have.
The proposed mechanism is different from MCAS, and it's really a gut health story. Rather than mast cells releasing too much histamine, histamine intolerance is thought to involve a mismatch between the histamine coming in through food and the body's ability to break it down — specifically through an enzyme called diamine oxidase (DAO), which is produced largely in the gut lining and clears histamine there before it reaches general circulation. If DAO activity is lower than it should be — which can happen with genetics, certain medications, or conditions that affect gut barrier integrity, like inflammatory bowel disease — histamine from food may build up and cause symptoms. This is one of the reasons histamine intolerance so often gets tangled up with broader gut health concerns like IBS: an irritated or inflamed gut lining can plausibly affect DAO output, even though the research connecting the two directly is still limited.
A few useful distinctions from MCAS:
HIT symptoms are tied to food, typically showing up after eating histamine-rich items (aged cheese, cured meats, fermented foods, wine, leftovers). Symptoms that show up in the middle of the night, hours removed from a meal, are less likely to be histamine-related.
DAO testing exists, though it isn't widely available and isn't perfectly standardized. Research suggests people with genuinely low DAO levels tend to have more frequent symptoms and respond better to both low-histamine diets and DAO supplementation — while people with normal DAO who still have symptoms may be dealing with something else entirely (a true food allergy is worth ruling out first, since treating a real allergy as histamine intolerance won't help).
The "low histamine diet" is surprisingly inconsistent. Researchers who reviewed multiple published low-histamine food lists found that most recommendations weren't actually based on measured histamine content in food — many were based on a theory that certain foods "release" histamine in the body, which hasn't been well proven. The one point of universal agreement across studies: avoid fermented foods, since bacterial fermentation is a major source of dietary histamine.
DAO supplementation shows mixed but promising results, mainly in people who test as truly DAO-deficient. It doesn't help everyone, and study results in migraine and hives were inconsistent overall — though they tended to look better in the subgroup with confirmed low DAO.
An important caution: researchers studying histamine intolerance have flagged real overlap between people seeking care for suspected HIT and disordered eating patterns, particularly around excessive dietary restriction and "diet research" behavior. Because there's no definitive test, a low-histamine diet can become a slippery slope of ever-tightening food rules without much payoff. The recommended approach in current literature is a short, structured trial — a few weeks of restriction, followed by a careful, staged reintroduction — rather than an open-ended elimination diet. If a low-histamine approach is going to help, it should show results quickly. Months of restriction without improvement is a sign to reconsider the diagnosis, not to restrict further.
Histamine, Hormones, and Menopause
One piece that's often left out of the MCAS and histamine intolerance conversation: hormones — especially estrogen — have a direct relationship with both mast cells and histamine clearance. Mast cells carry estrogen receptors, and estrogen has been shown to encourage mast cells to release histamine while also slowing down DAO, the same enzyme responsible for clearing histamine from the gut. Progesterone tends to do the opposite — it has a stabilizing effect on mast cells and supports DAO activity. Some researchers describe a feedback loop where histamine can, in turn, stimulate more estrogen production, which is part of why symptoms can feel cyclical for many women (Briden).
This matters most during perimenopause and menopause, when estrogen becomes erratic and progesterone typically declines first, sometimes years earlier. That shifting ratio — falling progesterone alongside fluctuating estrogen — is thought to be one reason flushing, hives, new food sensitivities, and other histamine-type symptoms often emerge or worsen for the first time in a woman's 40s and 50s, even in people with no prior history of allergic-type reactions (Carnahan). It's worth noting this area is driven more by clinical observation and mechanistic research than by large controlled trials, so it should be treated as a plausible contributing factor to investigate — not a confirmed diagnosis on its own.
If you're navigating new or worsening histamine symptoms around perimenopause or menopause, it's worth looking at hormone balance and gut health together, rather than treating them as separate issues.
Frequently Asked Questions
What's the difference between MCAS and histamine intolerance? MCAS involves mast cells releasing excess histamine (and other mediators) from within the body, often with symptoms across multiple organ systems that aren't tied to eating. Histamine intolerance is thought to stem from reduced DAO enzyme activity in the gut, so symptoms are typically triggered by eating histamine-rich foods.
Can menopause cause histamine intolerance or MCAS-like symptoms? Menopause doesn't directly cause either condition, but the hormonal shifts of perimenopause and menopause — particularly falling progesterone and fluctuating estrogen — can increase mast cell reactivity and reduce DAO activity, which may explain why histamine-related symptoms like flushing, hives, and new food sensitivities often appear or intensify during this transition.
Is histamine intolerance related to gut health? Yes — DAO, the enzyme responsible for breaking down dietary histamine, is produced primarily in the gut lining. Conditions that affect gut barrier integrity, such as IBD, have been associated with lower DAO activity, which is one reason histamine intolerance and broader gut health issues like IBS often overlap.
Should I see a naturopath for MCAS or histamine intolerance? A naturopathic doctor can be a helpful part of the care team for investigating diet, gut health, and hormone-related contributors to histamine symptoms, alongside — not instead of — appropriate medical workup to rule out food allergies, systemic mastocytosis, and other conditions that require conventional diagnosis and treatment.
The Bottom Line
MCAS and histamine intolerance both center on histamine, but they're different problems: one is about mast cells releasing too much of it internally, the other is about the body's ability to clear it from food. Both fields are still young, both are prone to overdiagnosis in casual online discussion, and both deserve a real workup — ruling out other explanations, testing where possible, and watching for a genuine, timely response to treatment — rather than a self-applied label based on symptom overlap alone.
If you suspect either condition, the most useful first step is a conversation with a doctor who can help rule out food allergies, other autoimmune or endocrine conditions, and more serious mast cell disorders like systemic mastocytosis before settling on a diagnosis.
This article summarizes current clinical and research literature on MCAS and histamine intolerance for general information purposes. It isn't medical advice — talk to a healthcare provider about your specific symptoms and treatment options.
Looking for support with histamine symptoms, gut health, or hormone balance during perimenopause and menopause? As a naturopathic doctor based in Toronto, I work with patients to sort through overlapping symptoms like these, build a proper workup plan, and design a gut- and hormone-focused approach that fits their specific picture. Book a consultation to get started.